DQB1 Locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe

Sleep

Volumn 37, Issue 1, 2014, Pages 19-25

  Tafti, Mehdi ^a,b   Hor, Hyun ^a,c   Dauvilliers, Yves ^d,e   Lammers, Gert J ^e,g   Overeem, Sebastiaan ^h   Mayer, Geert ⁱ   Javidi, Sirous ⁱ   Iranzo, Alex ^j   Santamaria, Joan ^j   Peraita Adrados, Rosa ^k   Vicario, José L ^l   Arnulf, Isabelle ^m   Plazzi, Giuseppe ⁿ   Bayard, Sophie ^d,e,f   Poli, Francesca ⁿ   Pizza, Fabio ⁿ   Geisler, Peter ^o   Wierzbicka, Aleksandra ^p   Bassetti, Claudio L ^q   Mathis, Johannes ^q   Lecendreux, Michel ^r   Donjacour, Claire E H M ^e   Van Der Heide, Astrid ^e   Heinzer, Raphaël ^b   Haba Rubio, José ^b   Feketeova, Eva ^s   Högl, Birgit ^t   Frauscher, Birgit ^t   Benetó, Antonio ^u   Khatami, Ramin ^v   Cañellas, Francesca ^w   Pfister, Corinne ^a   Scholz, Sabine ^e   Billiard, Michel ^e   Baumann, Christian R ^x   Ercilla, Guadalupe ^y   Verduijn, Willem ^f   Claas, Frans H J ^f   Dubois, Valérie ^z,aa   Nowak, Jacek ^y   Eberhard, Hans Peter ^ab   Pradervand, Sylvain ^a,ac   Hor, Charlotte N ^c   Testi, Manuela ^ad   Tiercy, Jean Marie ^ae   Kutalik, Zoltán ^a,ac,af   more..

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d INSERM U1061   (France)

^e GUI DE CHAULIAC HOSPITAL   (France)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^h EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

ⁱ Hephata Clinic for Neurology   (Germany)

^j INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^k HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^l Blood Center of the Community of Madrid ^*  (Spain)

^m PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁿ UNIVERSITY OF BOLOGNA   (Italy)

^o UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^p INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^q UNIVERSITY OF BERN   (Switzerland)

^r UNIVERSITÉ PARIS DESCARTES   (France)

^s FACULTY HOSPITAL   (Slovakia)

^t INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^u HOSPITAL UNIVERSITARIO LA FE   (Spain)

^v Clinic Barmelweid   (Switzerland)

^w HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^x UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^y HOSPITAL CLÍNIC   (Spain)

^z ETABLISSEMENT FRANÇAIS DU SANG   (France)

^aa INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^ab German National Bone Marrow Donor Registry   (Germany)

^ac SWISS INSTITUTE OF BIOINFORMATICS   (Switzerland)

^ad International Centre for Transplantation in Thalassemia and Sickle Cell Anemia   (Italy)

^ae GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^af UNIVERSITY OF LAUSANNE   (Switzerland)

more..

Author keywords

Autoimmunity; Genetics; GWAS; H1N1 vaccination

Indexed keywords

DEOXYRIBONUCLEASE I; HLA DQB1 ANTIGEN;

ALLELE; ARTICLE; CASE CONTROL STUDY; CATAPLEXY; COMPARATIVE STUDY; CONTROLLED STUDY; EUROPE; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HAPLOTYPE; HLA SYSTEM; HUMAN; INTRON; ITALY; MAJOR CLINICAL STUDY; NARCOLEPSY; NETHERLANDS; PHENOTYPE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTECTION; RETROSPECTIVE STUDY; SINGLE NUCLEOTIDE POLYMORPHISM; SPAIN;

AUTOIMMUNITY; GENETICS; GWAS; H1N1 VACCINATION;

ALLELES; CATAPLEXY; DEOXYRIBONUCLEASE I; EUROPE; EUROPEAN CONTINENTAL ANCESTRY GROUP; EXOME; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HLA-DQ BETA-CHAINS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; NARCOLEPSY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RETROSPECTIVE STUDIES; VACCINATION;

EID: 84891810535     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.3300     Document Type: Article

References (27)

1. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007;369:499-511.
2. Luca G, Haba-Rubio J, Dauvilliers Y, et al. Clinical, polysomnographic and genome-wide association analyses of narcolepsy with cataplexy: a European Narcolepsy Network study. J Sleep Res 2013;22:482-95.
3. Mignot E, Hayduk R, Black J, Grumet FC, Guilleminault C. HLA DQB1 0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997;20:1012-20.
4. Peyron C, Faraco J, Rogers W, et al. A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains. Nat Med 2000;6:991-7.
5. Nishino S, Ripley B, Overeem S, Lammers GJ, Mignot E. Hypocretin (orexin) deficiency in human narcolepsy. Lancet 2000;355:39-40.
6. Hallmayer J, Faraco J, Lin L, et al. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009;41:708-11.
7. Hor H, Kutalik Z, Dauvilliers Y, et al. Genome-wide association study identifies new HLA class II haplotypes strongly protective against narcolepsy. Nat Genet 2010;42:786-9.
8. Kornum BR, Kawashima M, Faraco J, et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011;43:66-71.
9. Cvetkovic-Lopes V, Bayer L, Dorsaz S, et al. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. J Clin Invest 2010;120:713-9.
10. Kawashima M, Lin L, Tanaka S, et al. Anti-Tribbles homolog 2 (TRIB2) autoantibodies in narcolepsy are associated with recent onset of cataplexy. Sleep 2010;33:869-74.
11. Toyoda H, Tanaka S, Miyagawa T, Honda Y, Tokunaga K, Honda M. Anti- Tribbles homolog 2 autoantibodies in Japanese patients with narcolepsy. Sleep 2010;33:875-8.
12. Dauvilliers Y, Montplaisir J, Cochen V, et al. Post-H1N1 narcolepsycataplexy. Sleep 2010;33:1428-30.
13. Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PLoS One 2012;7:e33536.
14. Szakacs A, Darin N, Hallbook T. Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination. Neurology 2013;80:1315-21.
15. Wijnans L, Lecomte C, de Vries C, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013;31:1246-54.
16. Faraco J, Lin L, Kornum BR, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 2013;9:e1003270.
17. American Academy of Sleep Medicine. International Classification of Sleep Disorders, 2nd ed.: Diagnostic and Coding Manual. Westchester, IL: American Academy of Sleep Medicine, 2005.
18. Han F, Lin L, Li J, et al. HLA-DQ association and allele competition in Chinese narcolepsy. Tissue Antigens 2012;80:328-35.
19. Maurano MT, Humbert R, Rynes E, et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 2012;337:1190-5.
20. Rogers AE, Meehan J, Guilleminault C, Grumet FC, Mignot E. HLA DR15 (DR2) and DQB1 0602 typing studies in 188 narcoleptic patients with cataplexy. Neurology 1997;48:1550-6.
21. Lock CB, So AK, Welsh KI, Parkes JD, Trowsdale J. MHC class II sequences of an HLA-DR2 narcoleptic. Immunogenetics 1988;27:449-55.
22. Uryu N, Maeda M, Nagata Y, et al. No difference in the nucleotide sequence of the DQ beta beta 1 domain between narcoleptic and healthy individuals with DR2,Dw2. Hum Immunol 1989;24:175-81.
23. Hong SC, Lin L, Lo B, et al. DQB1, 0301 and DQB1, 0601 modulate narcolepsy susceptibility in Koreans. Hum Immunol 2007;68:59-68.
24. Mignot E, Lin L, Rogers W, et al. Complex HLA-DR and -DQ interactions confer risk of narcolepsy-cataplexy in three ethnic groups. Am J Hum Genet 2001;68:686-99.
25. Koeleman BP, Lie BA, Undlien DE, et al. Genotype effects and epistasis in type 1 diabetes and HLA-DQ trans dimer associations with disease. Genes Immun 2004;5:381-8.
26. Matsuki K, Grumet FC, Lin X, et al. DQ (rather than DR) gene marks susceptibility to narcolepsy. Lancet 1992;339:1052.
27. Mignot E, Kimura A, Lattermann A, et al. Extensive HLA class II studies in 58 non-DRB115 (DR2) narcoleptic patients with cataplexy. Tissue Antigens 1997;49:329-41.